Nuformix (LON:NFX) Stock Price Down 10% – Should You Sell?

Shares of Nuformix plc ( LON:NFX – Get Free Report ) were down 10% during mid-day trading on Monday . The stock traded as low as GBX 0.05 ($0.

00) and last traded at GBX 0.05 ($0.00).



Approximately 1,986,748 shares were traded during trading, a decline of 82% from the average daily volume of 10,762,529 shares. The stock had previously closed at GBX 0.05 ($0.

00). Nuformix Price Performance The company has a 50 day moving average of GBX 0.05 and a 200 day moving average of GBX 0.

12. The company has a quick ratio of 3.35, a current ratio of 1.

12 and a debt-to-equity ratio of 1.17. The stock has a market capitalization of £368,689.

50, a price-to-earnings ratio of -1.63 and a beta of 1.22.

Nuformix Company Profile ( Get Free Report ) Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.

See Also Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter ..